Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Sewa Rijal


Sewa Rijal

Monash University, Australia

Biography

Sewa Rijal has completed her PhD from Monash University. She recently published her work in the prestigious journal, blood of identifying a novel prognostic biomarker protein known as INPP4B in acute myeloid leukemia. Her work was part of an inside blood commentary and also highlighted in the Australian media by ABC news as a major breakthrough. Her finding has important implications in defining prognosis and treatment options for AML patients. She is currently undertaking Post-doctoral studies to understand the mechanism of INPP4B-mediated chemo-resistance in AML so that novel therapeutics may be designed for patients who fail chemotherapy.

Abstract

Abstract : Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemo-resistance and poor outcome in AML